… legal battles over the patents involved. Moderna sparred … patents related to the delivery of mRNA shots. Weeks later, Alnylam … the companies violated an Alnylam patent on lipid nanoparticle technology … infringement on different patents stemming from the work …

Image from Shutterstock/Kateryna Kon BioNTech and its partner has defeated CureVac in UK litigation just days after Moderna fended off Alnylam stateside Register for limited access Register to receive our newsletter and gain limited access to …

… their ongoing patent infringement litigation. In 2022, Alnylam filed a patent infringement lawsuit … delivery systems and violates an Alnylam patent on lipid nanoparticle (LNP) technology … products do not infringe on Alnylam’s patents. Both parties have agreed …

Alnylam Pharma has been riding … taking vutrisiran and Vyndamax together. Alnylam’s chief medical officer Pushkal … ATTR cardiomyopathy and polyneuropathy. Basic patents are however due to expire … been working to extend its patent life but several generic …

… so long. Read more. Patent-targeting bill was watered down … of so-called “patent thickets,” the slew of patents that companies hold … hour (for now) for Alnylam Shares of Alnylam have been riding high … month, but for now, Alnylam’s founding CEO John Maraganore …

… Strategic Focus on RNAi Therapeutics Alnylam Pharmaceuticals continues to pioneer the … leading drug Amvuttra. Company Overview Alnylam Pharmaceuticals, with a market … pricing pressures. - Uncertainties around patent expirations and market exclusivity. …

… Heart Association (NYHA) Class. Alnylam’s chief executive, Yvonne Greenstreet … in ATTR-polyneuropathy alone. Alnylam thinks it could get … similar benefit.  The first patents on tafamidis are due to … off potential rivals until other patents expire, in one case …

… has sued them for patent infringement. The company also … has filed requests for patent term extensions that are … growth, and its looming patent questions, are also important … be competitors BridgeBio Pharma and Alnylam Pharmaceuticals. BridgeBio is currently …

… key innovation area identified from patents. Alnylam Pharmaceuticals's grant … Patent and Trademark Office (USPTO). Credit: Alnylam Pharmaceuticals Inc A recently granted patent … produce this article. GlobalData Patent Analytics tracks bibliographic data, …